blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2292592

EP2292592 - SULFONAMIDE COMPOUND AND APPLICATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.07.2013
Database last updated on 02.08.2024
Most recent event   Tooltip03.07.2015Lapse of the patent in a contracting state
New state(s): MK
published on 05.08.2015  [2015/32]
Applicant(s)For all designated states
Asahi Kasei Pharma Corporation
1-105 Kanda Jinbocho Chiyoda-ku
Tokyo 101-8101 / JP
[2011/10]
Inventor(s)01 / OGAWA Masami
1-105 Kanda Jinbocho
Chiyoda-ku
Tokyo 101-8101 / JP
02 / KITAGAWA Kazuhiko
1-105 Kanda Jinbocho
Chiyoda-ku
Tokyo 101-8101 / JP
03 / SHIRAHASHI Hiromitsu
1-105 Kanda Jinbocho
Chiyoda-ku
Tokyo 101-8101 / JP
04 / KURIBAYASHI Satomi
1-105 Kanda Jinbocho
Chiyoda-ku
Tokyo 101-8101 / JP
 [2012/36]
Former [2011/10]01 / OGAWA Masami
1-105 Kanda Jinbocho Chiyoda-ku
Tokyo 101-8101 / JP
02 / KITAGAWA Kazuhiko
1-105 Kanda Jinbocho Chiyoda-ku
Tokyo 101-8101 / JP
03 / SHIRAHASHI Hiromitsu
1-105 Kanda Jinbocho Chiyoda-ku
Tokyo 101-8101 / JP
04 / KURIBAYASHI Satomi
1-105 Kanda Jinbocho Chiyoda-ku
Tokyo 101-8101 / JP
Representative(s)Forstmeyer, Dietmar, et al
Boeters & Lieck
Oberanger 32
80331 München / DE
[N/P]
Former [2011/10]Forstmeyer, Dietmar, et al
BOETERS & LIECK Oberanger 32
80331 München / DE
Application number, filing date09758319.902.06.2009
[2011/10]
WO2009JP60060
Priority number, dateUS2008005898505.06.2008         Original published format: US 58985
[2011/10]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009148052
Date:10.12.2009
Language:JA
[2009/50]
Type: A1 Application with search report 
No.:EP2292592
Date:09.03.2011
Language:EN
[2011/10]
Type: B1 Patent specification 
No.:EP2292592
Date:05.09.2012
Language:EN
[2012/36]
Search report(s)International search report - published on:JP10.12.2009
(Supplementary) European search report - dispatched on:EP26.07.2011
ClassificationIPC:C07C311/18, A61K31/216, A61K31/235, A61K31/381, A61K31/44, A61K31/4436, A61P5/20, A61P17/00, A61P17/14, A61P19/00, A61P19/10, C07C311/29, C07D213/36, C07D213/55, C07D333/24, C07D409/12, C07D333/34, C07D213/83
[2012/17]
CPC:
C07D333/34 (EP,US); A61P17/00 (EP); A61P17/14 (EP);
A61P19/00 (EP); A61P19/10 (EP); A61P43/00 (EP);
A61P5/20 (EP); C07C311/13 (EP,US); C07C311/18 (EP,US);
C07C311/29 (EP,US); C07C311/41 (EP,US); C07C311/46 (EP,US);
C07C323/32 (EP,US); C07C323/52 (EP,US); C07C323/67 (EP,US);
C07D213/36 (EP,US); C07D213/55 (EP,US); C07D213/79 (EP,US);
C07D213/83 (EP,US); C07D333/24 (EP,US); C07D409/12 (EP,US);
C07C2602/08 (EP,US) (-)
Former IPC [2011/10]C07C311/18, A61K31/18, A61K31/195, A61K31/196, A61K31/197, A61K31/198, A61K31/216, A61K31/235, A61K31/381, A61K31/44, A61K31/4436, A61P5/20, A61P17/00, A61P17/14, A61P19/00, A61P19/10, C07C311/29
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/10]
TitleGerman:SULFONAMIDVERBINDUNG UND IHRE ANWENDUNG[2011/10]
English:SULFONAMIDE COMPOUND AND APPLICATION THEREOF[2011/10]
French:COMPOSÉ DE SULFONAMIDE ET SON APPLICATION[2011/10]
Entry into regional phase29.10.2010Translation filed 
29.10.2010National basic fee paid 
29.10.2010Search fee paid 
29.10.2010Designation fee(s) paid 
04.01.2011Examination fee paid 
Examination procedure04.01.2011Examination requested  [2011/10]
08.02.2012Amendment by applicant (claims and/or description)
30.03.2012Communication of intention to grant the patent
09.07.2012Fee for grant paid
09.07.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  30.03.2012
Opposition(s)06.06.2013No opposition filed within time limit [2013/33]
Fees paidRenewal fee
25.05.2011Renewal fee patent year 03
30.03.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHR05.09.2012
LT05.09.2012
LV05.09.2012
MK05.09.2012
MT05.09.2012
NO05.12.2012
IS05.01.2013
[2015/32]
Former [2015/13]HR05.09.2012
LT05.09.2012
LV05.09.2012
MT05.09.2012
NO05.12.2012
IS05.01.2013
Former [2014/09]HR05.09.2012
LT05.09.2012
LV05.09.2012
NO05.12.2012
IS05.01.2013
Former [2013/52]CY05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
NO05.12.2012
IS05.01.2013
Former [2013/22]HR05.09.2012
LT05.09.2012
LV05.09.2012
NO05.12.2012
IS05.01.2013
Former [2013/11]HR05.09.2012
LT05.09.2012
LV05.09.2012
NO05.12.2012
Former [2013/10]HR05.09.2012
LT05.09.2012
NO05.12.2012
Former [2013/08]LT05.09.2012
NO05.12.2012
Documents cited:Search[A]US6022894  (DEL MAR ERIC G [US], et al) [A] 1-20 * claims 1-30 * * column 1, lines 12-15 * * column 4, lines 13-25 *;
 [A]EP1308436  (JAPAN TOBACCO INC [JP]) [A] 1-20 * claims 1-16 * * page 3, paragraph 1 * * page 4, paragraph 16 *
International search[X]JPH10500938  (VERTEX PHARMACEUTICALS INC.);
 [A]JP2006501282  (ELAN PHARMACEUTICALS, INC.)
by applicantWO9737967
 WO0214259
 WO2004069793
 WO2004106296
 WO2004041775
 WO2004017908
 WO03070686
    - NEER RM. ET AL., N. ENGL. J. MED., (2001), vol. 344, pages 1434 - 1441
    - MCCLUNG MR. ET AL., ARCH. INTERN. MED., (2005), vol. 165, pages 1762 - 1768
    - MIKI T. ET AL., J. BONE MINERAL METAB., (2004), vol. 22, pages 569 - 576
    - MATSUMOTO T. ET AL., OSTEOPOROSIS INT., (2006), vol. 17, pages 1532 - 1538
    - BROWN EM. ET AL., NATURE, (1993), vol. 366, pages 575 - 580
    - GOWEN M. ET AL., J. CLIN. INVEST., (2000), vol. 105, pages 1595 - 1604
    - UZAWA T. ET AL., BONE, (1995), vol. 16, pages 477 - 484
    - "Esterification using an alcohol", New Experimental Chemistry Series, MARUZEN PUBLISHING COMPANY, vol. 14, page 1002
    - "Esterification using an 0-alkylating agent", NEW EXPERIMENTAL CHEMISTRY SERIES, page 1002
    - "Esterification using a alkyl halide", NEW EXPERIMENTAL CHEMISTRY SERIES, page 1008
    - "Esterification reaction using a dehydrating agent", NEW EXPERIMENTAL CHEMISTRY SERIES, vol. 22, page 45
    - Experimental Chemistry Series, MARUZEN, vol. 24
    - "Organic Syntheses Via Boranes", Suzuki Coupling, ALDRICH CHEMICAL COMPANY, INC., (2003), vol. 3
    - Experimental Chemistry Series, MARUZEN, vol. 22
    - CHACHIN, M. ET AL., NIPPON YAKURIGAKU ZASSHI, (2002), vol. 119, pages 345 - 351
    - GILBERT, J.D. ET AL., J. PHARM. TOX. METHODS, (2004), vol. 50, pages 187 - 199
    - CHENG, C.S. ET AL., DRUG DEVELOP. INDUST. PHARM., (2002), vol. 28, pages 177 - 191
    - DORN, A. ET AL., J. BIOMOL. SCREEN., (2005), vol. 10, pages 339 - 347
    - GOMEZ-LECHON, M.J. ET AL., CURR. DRUG METAB., (2004), vol. 5, no. 5, pages 443 - 462
    - MILLER, V.P. ET AL., ANN. N.Y. ACAD. SCI., (2000), vol. 919, pages 26 - 32
    - HENGSTLER, J.G. ET AL., DRUG METAB. REV., (2000), vol. 32, pages 81 - 118
    - LIPINSKI, C.A. ET AL., ADV. DRUG DELIV. REV., (1997), vol. 23, pages 3 - 26
    - BEVAN, C.D. ET AL., ANAL. CHEM., (2000), vol. 72, pages 1781 - 1787
    - J. ORG. CHEM., (1976), vol. 41, no. 2, pages 265 - 272
    - J. ORG. CHEM., (1987), vol. 52, pages 4665 - 4673
    - TETRAHEDRON LETTERS, (2000), vol. 41, pages 4335 - 4338
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.